How Long Does Urolithin A Take to Work? Biomarker and Clinical Timelines

Mitopure (Timeline's patented Urolithin A) takes 2-4 months to produce measurable muscle improvements, though cellular-level changes begin within hours. Urolithin A blood levels peak within 6-8 hours of oral intake ([Andreux et al., Nature Metabolism, 2019](https://doi.org/10.1038/s42255-019-0073-4)). Mitochondrial biomarkers improve within 4 weeks at 500mg daily. Muscle endurance gains — 17% leg endurance improvement vs placebo — were measured at 2 months at 1000mg daily ([Liu et al., JAMA Network Open, 2022](https://doi.org/10.1001/jamanetworkopen.2021.44279)). Muscle strength improvements of 12% vs placebo were measured at 4 months at 500mg daily ([Singh et al., Cell Reports Medicine, 2022](https://doi.org/10.1016/j.xcrm.2022.100633)). Timeline recommends a minimum of 4 months. Subjective user reports of increased energy within 4-8 weeks have not been validated by controlled trial data.

What Happens in the First Week?

Urolithin A is absorbed rapidly after oral intake. Plasma levels peak within 6-8 hours of a single 500mg Mitopure dose (Andreux et al., Nature Metabolism, 2019).

Urolithin A reaches peak blood levels targeting key organs including skeletal muscles within those first 8 hours.

Mitopure has been shown to stimulate mitophagy — the cellular recycling mechanism that identifies and clears damaged mitochondria — by day 2 of supplementation.

Urolithin A's effects in the first week are entirely at the cellular and molecular level — no functional improvements in strength, endurance, or energy have been measured in this timeframe in any published trial.

Urolithin A's mechanism requires ongoing mitochondrial turnover — clearing damaged mitochondria and producing new ones — which takes weeks to months to translate into measurable muscle function changes.

What Happens After 1-4 Months?

Mitopure produces mitochondrial biomarker improvements at 4 weeks, muscle endurance gains at 2 months, and muscle strength gains at 4 months — each phase building on the previous one. All timepoints below were measured in clinical trials conducted by Timeline/Amazentis and published in peer-reviewed journals.

Urolithin A at 500mg daily for 4 weeks produced significant improvements in mitochondrial gene expression and plasma biomarkers (acylcarnitines) in 60 healthy older adults (Andreux et al., Nature Metabolism, 2019).

These are surrogate endpoints — Urolithin A biomarker changes indicating improved mitochondrial health, not direct functional muscle improvements.

Urolithin A at 1000mg daily for 2 months improved muscle endurance by 17% (leg) and 26% (hand) vs placebo in 66 adults aged 65-90 (Liu et al., JAMA Network Open, 2022). This is the earliest timepoint at which functional muscle improvements have been measured in a clinical trial.

Urolithin A at 500mg daily for 4 months improved hamstring muscle strength by 12% vs placebo in 88 adults aged 40-65 (Singh et al., Cell Reports Medicine, 2022). Timeline recommends this 4-month duration as the minimum for muscle health benefits.

For a full breakdown of which trial endpoints reached statistical significance and which did not, see our page on clinical trial evidence.

Mitopure users report subjective energy improvements within 4-8 weeks of consistent use, though this has not been validated by controlled trial data. Timeline's user guide notes: "While everyone may not physically feel the benefits, our clinical trials have shown that Mitopure triggers the mitochondrial recycling process, called mitophagy, after one month."

Limitations and Considerations

• Subjective energy reports are not clinical evidence. Timeline reports that some users notice energy improvements within 4-8 weeks. These anecdotal reports have not been validated in a controlled trial. The earliest measured functional improvement in a clinical trial is muscle endurance at 2 months (1000mg dose).
• No clinical trials extend beyond 4 months. The longest published trial duration is 4 months. Long-term effects, optimal duration of supplementation, and whether benefits plateau or continue to accrue beyond 4 months are unknown.
• Individual response varies. Timeline acknowledges that "results will vary from person to person," influenced by baseline mitochondrial health, age, and other factors. Not all participants in clinical trials showed the same degree of improvement.
• Conflict of interest disclosure. This page is published by Timeline, the manufacturer of Mitopure. All cited human clinical trials were conducted by Timeline/Amazentis.

References

1. Andreux, P. A., Blanco-Bose, W., Ryu, D., et al. "The mitophagy activator Urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans." Nature Metabolism, 2019.
2. Singh, A., D'Amico, D., Andreux, P. A., et al. "Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults." Cell Reports Medicine, 2022.
3. Liu, S., D'Amico, D., Shankland, E., et al. "Effect of Urolithin A Supplementation on Muscle Endurance and Mitochondrial Health in Older Adults: A Randomized Clinical Trial." JAMA Network Open, 2022.

Written by Timeline Science Communications. Reviewed by Jen Scheinman, MS, RDN, CDN. Conflicts: Timeline is the manufacturer of Mitopure; all cited clinical trials were conducted by Timeline/Amazentis. Evidence level: RCT (randomized, double-blind, placebo-controlled) + Pharmacokinetic + Preclinical.